Literature DB >> 28883764

Prognostic significance, diagnosis and treatment in patients with gastric cancer and positive peritoneal washings. A review of the literature.

Radosław Lisiecki1, Małgorzata Kruszwicka2, Arkadiusz Spychała3, Dawid Murawa3.   

Abstract

Peritoneal dissemination is a common consequence of a relapse following a radical surgical treatment of gastric cancer. The development of the disease in the peritoneum depends not only on its stage, but also on free cancer cells exfoliated from the tumor mass or from involved lymph nodes, and which are capable of being implanted in the peritoneum. According to the latest TNM (7 edition; 2010) classification, patients with free cancer cells in the peritoneal washings qualify for stage IV of the disease. Patients in whom free cancer cells were found during the operation - have a recurrence of gastric cancer - mainly in the peritoneum, and the majority of them die within two years of the diagnosis. To properly assess the prognosis, it is vital to determine the stage of cancer by additionally assessing the washings for the presence of free cancer cells before taking a therapeutic decision. This also allows identifying those patients who require different medical procedures to obtain the best treatment results possible. Medical literature describes various methods of examining peritoneal washings aimed at detecting free cancer cells. The methods apply different cancer cell detection rates, sensitivity and specificity in prediction of a peritoneal relapse. Oncological Departments performing the evaluation of the washings employ non-standard methods of treatment in this group of patients and the results presented are promising.

Entities:  

Keywords:  Chemotherapy; Free cancer cells; Gastric cancer; Peritoneal lavage; Peritoneal washings

Year:  2017        PMID: 28883764      PMCID: PMC5581864          DOI: 10.1016/j.rpor.2017.08.004

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  42 in total

1.  Peritoneal lavage cytology and carcinoembryonic antigen determination in predicting peritoneal metastasis and prognosis of gastric cancer.

Authors:  Ji-Kun Li; Miao Zheng; Chuan-Wen Miao; Jian-Hai Zhang; Guang-Han Ding; Wen-Shen Wu
Journal:  World J Gastroenterol       Date:  2005-12-14       Impact factor: 5.742

2.  [Detection of free cancer cells in peritoneal cavity in patients surgically treated for gastric adenocarcinoma].

Authors:  Zoran Kostić; Vladimir Cuk; Radojka Bokun; Dragan Ignjatović; Slavica Usaj-Knezević; Mile Ignjatović
Journal:  Vojnosanit Pregl       Date:  2006-04       Impact factor: 0.168

3.  E-cadherin and urokinase-type plasminogen activator tissue status in gastric carcinoma.

Authors:  Y Yonemura; N Nojima; M Kaji; T Fujimura; H Itoh; I Ninomiya; I Miyazaki; Y Endo; T Sasaki
Journal:  Cancer       Date:  1995-09-15       Impact factor: 6.860

4.  Intraoperative lavage for cytological examination in 1,297 patients with gastric carcinoma.

Authors:  E Bando; Y Yonemura; Y Takeshita; K Taniguchi; T Yasui; Y Yoshimitsu; S Fushida; T Fujimura; G Nishimura; K Miwa
Journal:  Am J Surg       Date:  1999-09       Impact factor: 2.565

5.  Gastric cancer cell detection in peritoneal lavage: RT-PCR for carcinoembryonic antigen transcripts versus the combined cytology with peritoneal carcinoembryonic antigen levels.

Authors:  Jaw-Yuan Wang; Shiu-Ru Lin; Chien-Yu Lu; Chung-Chi Chen; Deng-Chyang Wu; Chee-Yin Chai; Fang-Ming Chen; Jan-Sing Hsieh; Tsung-Jen Huang
Journal:  Cancer Lett       Date:  2004-10-28       Impact factor: 8.679

6.  Prognostic significance of free peritoneal tumor cells in the peritoneal cavity before and after neoadjuvant chemotherapy in patients with gastric carcinoma undergoing potentially curative resection.

Authors:  Sylvie Lorenzen; Benjamin Panzram; Robert Rosenberg; Hjalmar Nekarda; Karin Becker; Ulrich Schenk; Heinz Höfler; Jörg-Rüdiger Siewert; Dirk Jäger; Katja Ott
Journal:  Ann Surg Oncol       Date:  2010-05-19       Impact factor: 5.344

7.  Peritoneal washing cytology: prognostic value of positive findings in patients with gastric carcinoma undergoing a potentially curative resection.

Authors:  Y Kodera; Y Yamamura; Y Shimizu; A Torii; T Hirai; K Yasui; T Morimoto; T Kato
Journal:  J Surg Oncol       Date:  1999-10       Impact factor: 3.454

8.  Induction chemotherapy with S-1 plus cisplatin followed by surgery for treatment of gastric cancer with peritoneal dissemination.

Authors:  Hiroshi Okabe; Shugo Ueda; Kazutaka Obama; Hisahiro Hosogi; Yoshiharu Sakai
Journal:  Ann Surg Oncol       Date:  2009-09-24       Impact factor: 5.344

9.  Extensive intraoperative peritoneal lavage as a standard prophylactic strategy for peritoneal recurrence in patients with gastric carcinoma.

Authors:  Masafumi Kuramoto; Shinya Shimada; Satosi Ikeshima; Akinobu Matsuo; Yasushi Yagi; Masakazu Matsuda; Yutaka Yonemura; Hideo Baba
Journal:  Ann Surg       Date:  2009-08       Impact factor: 12.969

10.  Processes of care in the multidisciplinary treatment of gastric cancer: results of a RAND/UCLA expert panel.

Authors:  Savtaj S Brar; Alyson L Mahar; Lucy K Helyer; Carol Swallow; Calvin Law; Lawrence Paszat; Rajini Seevaratnam; Roberta Cardoso; Robin McLeod; Matthew Dixon; Lavanya Yohanathan; Laercio G Lourenco; Alina Bocicariu; Tanios Bekaii-Saab; Ian Chau; Neal Church; Daniel Coit; Christopher H Crane; Craig Earle; Paul Mansfield; Norman Marcon; Thomas Miner; Sung Hoon Noh; Geoff Porter; Mitchell C Posner; Vivek Prachand; Takeshi Sano; Cornelis van de Velde; Sandra Wong; Natalie G Coburn
Journal:  JAMA Surg       Date:  2014-01       Impact factor: 14.766

View more
  2 in total

1.  UHRF1 mediates cell migration and invasion of gastric cancer.

Authors:  Haixia Zhang; Yanli Song; Changqing Yang; Xianzheng Wu
Journal:  Biosci Rep       Date:  2018-12-18       Impact factor: 3.840

2.  Rapid Detection of Free Cancer Cells in Intraoperative Peritoneal Lavage Using One-Step Nucleic Acid Amplification (OSNA) in Gastric Cancer Patients.

Authors:  Katarzyna Gęca; Karol Rawicz-Pruszyński; Jerzy Mielko; Radosław Mlak; Katarzyna Sędłak; Wojciech P Polkowski
Journal:  Cells       Date:  2020-09-25       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.